Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018
Completed · Phase 3 · Has a placebo group
Conditions studied: Benign Prostatic Hyperplasia (BPH)
In brief
This study will evaluate the safety and efficacy of a 2.5 mg dose of NX-1207 for the treatment of BPH (benign prostatic hyperplasia) as compared to placebo.
Key facts
- Study ID
- NCT00945490
- Run by
- Nymox Corporation
- People needed
- 500
- Starts
- 2009-05-01
- Expected to finish
- 2014-05-01
- Last updated by the study team
- 2017-03-10
Who can join
Age: 45 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Provide signed informed consent prior to enrolment in the study
- AUASI ≥ 15
- Prostate Volume ≥ 30 mL ≤ 70 mL
- Qmax < 15 mL/sec based on a minimum void of 125 mL
- Agree not to use any other approved or experimental BPH or OAB medication anytime during the study
You may not qualify if…
- History of illness or condition that may interfere with study or endanger subject
- Use of prescribed medications that may interfere with study or endanger subject
- Presence of a median lobe of the prostate
- Previous surgery or MIST for treatment of BPH
- Post-void residual urine volume > 200 mL
- PSA ≥ 10 ng/mL; prostate cancer must be ruled out (negative biopsy) for PSA ≥ 4 ng/mL
- Participation in a study of any investigational drug or device within the previous 90 days
- Prostate cancer
Where it is running
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Laguna Hills, California, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — San Diego, California, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — San Diego, California, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Tarzana, California, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Torrance, California, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Denver, Colorado, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Englewood, Colorado, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Aventura, Florida, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Ocala, Florida, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Orlando, Florida, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Sarasota, Florida, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Meridian, Idaho, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Annapolis, Maryland, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Baltimore, Maryland, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Glen Burnie, Maryland, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Towson, Maryland, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669 — Grand Rapids, Michigan, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Sartell, Minnesota, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Southaven, Mississippi, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Las Vegas, Nevada, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Las Vegas, Nevada, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Brick, New Jersey, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Albuquerque, New Mexico, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Albany, New York, United States
- For information concerning this clinical site, please contact Nymox at 800-936-9669. — Garden City, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.